FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 346:884-890 March 21, 2002 Number 12 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

ABSTRACT

Background Lidocaine has been the initial antiarrhythmic drug treatment recommended for patients with ventricular fibrillation that is resistant to conversion by defibrillator shocks. We performed a randomized trial comparing intravenous lidocaine with intravenous amiodarone as an adjunct to defibrillation in victims of out-of-hospital cardiac arrest.

Methods Patients were enrolled if they had out-of-hospital ventricular fibrillation resistant to three shocks, intravenous epinephrine, and a further shock; or if they had recurrent ventricular fibrillation after initially successful defibrillation. They were randomly assigned in a double-blind manner to receive intravenous amiodarone plus lidocaine placebo or intravenous lidocaine plus amiodarone placebo. The primary end point was the proportion of patients who survived to be admitted to the hospital.

Results In total, 347 patients (mean [±SD] age, 67±14 years) were enrolled. The mean interval between the time at which paramedics were dispatched to the scene of the cardiac arrest and the time of their arrival was 7±3 minutes, and the mean interval from dispatch to drug administration was 25±8 minutes. After treatment with amiodarone, 22.8 percent of 180 patients survived to hospital admission, as compared with 12.0 percent of 167 patients treated with lidocaine (P=0.009; odds ratio, 2.17; 95 percent confidence interval, 1.21 to 3.83). Among patients for whom the time from dispatch to the administration of the drug was equal to or less than the median time (24 minutes), 27.7 percent of those given amiodarone and 15.3 percent of those given lidocaine survived to hospital admission (P=0.05).

Conclusions As compared with lidocaine, amiodarone leads to substantially higher rates of survival to hospital admission in patients with shock-resistant out-of-hospital ventricular fibrillation.

Source Information

From the Departments of Medicine and Emergency Medicine, St. Michael's Hospital (P.D., D.C., R.G., A.B.); the Division of Prehospital Care, Sunnybrook and Women's College Health Sciences Centre (B.S.); and the Department of Anesthesia, University Health Network (R.C.) — all in Toronto.

Address reprint requests to Dr. Dorian at St. Michael's Hospital, 30 Bond St., Toronto, ON M5B 1W8, Canada, or at dorianp{at}smh.toronto.on.ca.

Full Text of this Article

Related Letters:

Amiodarone versus Lidocaine for Shock-Resistant Ventricular Fibrillation
Silfvast T., Pettilä V., Ballew K. A., Philbrick J. T., Tomkiewicz W., Meininghaus D. G., Langes K., Spehn J., Dorian P., Schwartz B., Cooper R.
Extract | Full Text | PDF  
N Engl J Med 2002; 347:368-370, Aug 1, 2002. Correspondence

This article has been cited by other articles:

• Nichol, G., Thomas, E., Callaway, C. W., Hedges, J., Powell, J. L., Aufderheide, T. P., Rea, T., Lowe, R., Brown, T., Dreyer, J., Davis, D., Idris, A., Stiell, I. (2008). Regional Variation in Out-of-Hospital Cardiac Arrest Incidence and Outcome. JAMA 300: 1423-1431 [Abstract] [Full Text]  
• Nichol, G., Rumsfeld, J., Eigel, B., Abella, B. S., Labarthe, D., Hong, Y., O'Connor, R. E., Mosesso, V. N., Berg, R. A., Leeper, B. B., Weisfeldt, M. L. (2008). Essential Features of Designating Out-of-Hospital Cardiac Arrest as a Reportable Event: A Scientific Statement From the American Heart Association Emergency Cardiovascular Care Committee; Council on Cardiopulmonary, Perioperative, and Critical Care; Council on Cardiovascular Nursing; Council on Clinical Cardiology; and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 117: 2299-2308 [Abstract] [Full Text]  
• Tomlinson, D R, Cherian, P, Betts, T R, Bashir, Y (2008). Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?. Emerg. Med. J. 25: 15-18 [Abstract] [Full Text]  
• Levy, J. H., Tanaka, K. A., Bailey, J. M. (2008). Cardiac Surgical Pharmacology. Card Surg Adult 3: 77-110 [Full Text]  
• Anstadt, M. P., Lowe, J. E. (2008). Cardiopulmonary Resuscitation. Card Surg Adult 3: 487-506 [Full Text]  
• Vassallo, P., Trohman, R. G. (2007). Prescribing Amiodarone: An Evidence-Based Review of Clinical Indications. JAMA 298: 1312-1322 [Abstract] [Full Text]  
• Singh, B. N., Aliot, E. (2007). Newer antiarrhythmic agents for maintaining sinus rhythm in atrial fibrillation: simplicity or complexity?. Eur Heart J Suppl 9: G17-G25 [Abstract] [Full Text]  
• Ali, B., Zafari, A. M. (2007). Narrative Review: Cardiopulmonary Resuscitation and Emergency Cardiovascular Care: Review of the Current Guidelines. ANN INTERN MED 147: 171-179 [Abstract] [Full Text]  
• Wang, S., Radhakrishnan, J., Ayoub, I. M., Kolarova, J. D., Taglieri, D. M., Gazmuri, R. J. (2007). Limiting sarcolemmal Na+ entry during resuscitation from ventricular fibrillation prevents excess mitochondrial Ca2+ accumulation and attenuates myocardial injury. J. Appl. Physiol. 103: 55-65 [Abstract] [Full Text]  
• McClure, K. B, Delorio, N. M, Schmidt, T. A, Chiodo, G., Gorman, P. (2007). A qualitative study of institutional review board members' experience reviewing research proposals using emergency exception from informed consent. J. Med. Ethics 33: 289-293 [Abstract] [Full Text]  
• Zhong, J.-q., Laurent, G., So, P. P.-S., Xudong Hu, , Hennan, J. K., Dorian, P. (2007). Effects of Rotigaptide, a Gap Junction Modifier, on Defibrillation Energy and Resuscitation From Cardiac Arrest in Rabbits. J CARDIOVASC PHARMACOL THER 12: 69-77 [Abstract]  
• Yannopoulos, D., Aufderheide, T. (2007). Acute management of sudden cardiac death in adults based upon the new CPR guidelines. Europace 9: 2-9 [Abstract] [Full Text]  
• Developed in Collaboration With the European Heart, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L. (2006). ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 48: e247-e346 [Full Text]  
• Writing Committee Members, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B. (2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8: 746-837 [Full Text]  
• American Heart Association, (2006). 2005 American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC) of Pediatric and Neonatal Patients: Pediatric Advanced Life Support. Pediatrics 117: e1005-e1028 [Full Text]  
• The International Liaison Committee on Resuscitati, (2006). The International Liaison Committee on Resuscitation (ILCOR) Consensus on Science With Treatment Recommendations for Pediatric and Neonatal Patients: Pediatric Basic and Advanced Life Support. Pediatrics 117: e955-e977 [Abstract] [Full Text]  
• (2005). Part 1: Introduction. Circulation 112: IV-1-IV-5 [Full Text]  
• (2005). Part 7.2: Management of Cardiac Arrest. Circulation 112: IV-58-IV-66 [Full Text]  
• (2005). Part 7.3: Management of Symptomatic Bradycardia and Tachycardia. Circulation 112: IV-67-IV-77 [Full Text]  
• (2005). Part 12: Pediatric Advanced Life Support. Circulation 112: IV-167-IV-187 [Full Text]  
• Hazinski, M. F., Nadkarni, V. M., Hickey, R. W., O'Connor, R., Becker, L. B., Zaritsky, A. (2005). Major Changes in the 2005 AHA Guidelines for CPR and ECC: Reaching the Tipping Point for Change. Circulation 112: IV-206-IV-211 [Full Text]  
• Marill, K. A., Ellinor, P. T. (2005). Case 37-2005 -- A 35-Year-Old Man with Cardiac Arrest while Sleeping. NEJM 353: 2492-2501 [Full Text]  
• (2005). Part 4: Advanced Life Support. Circulation 112: III-25-III-54 [Full Text]  
• (2005). Part 6: Pediatric Basic and Advanced Life Support. Circulation 112: III-73-III-90 [Full Text]  
• Thompson, A., Balser, J. R. (2004). Perioperative cardiac arrhythmias. Br J Anaesth 93: 86-94 [Abstract] [Full Text]  
• Lader, E. W., Cannon, C. P., Ohman, E. M., Newby, L. K., Sulmasy, D. P., Barst, R. J., Fair, J. M., Flather, M., Freedman, J. E., Frye, R. L., Hand, M. M., Jesse, R. L., Van de Werf, F., Costa, F. (2004). The Clinician as Investigator: Participating in Clinical Trials in the Practice Setting. Circulation 109: 2672-2679 [Abstract] [Full Text]  
• Singh, B. N. (2003). More on Amiodarone-Meeting the Challenges of the Combined Epidemics of Heart Failure and Atrial Fibrillation?. J CARDIOVASC PHARMACOL THER 8: 175-178  
• Srivatsa, U. N., Ebrahimi, R., El-Bialy, A., Wachsner, R. Y. (2003). Electrical Storm: Case Series and Review of Management. J CARDIOVASC PHARMACOL THER 8: 237-246 [Abstract]  
• Bailey, J. M., Tanaka, K. A., Levy, J. H. (2003). Cardiac Surgical Pharmacology. Card Surg Adult 2: 85-118 [Full Text]  
• Wyatt, J., Bellis, F. (2002). JournalScan. Emerg. Med. J. 19: 435-436 [Full Text]  
• Silfvast, T., Pettila, V., Ballew, K. A., Philbrick, J. T., Tomkiewicz, W., Meininghaus, D. G., Langes, K., Spehn, J., Dorian, P., Schwartz, B., Cooper, R. (2002). Amiodarone versus Lidocaine for Shock-Resistant Ventricular Fibrillation. NEJM 347: 368-370 [Full Text]  
• Singh, B. N. (2002). Antiarrhythmic Drugs in Cardiac Arrest Resuscitation: Intravenous Amiodarone or Intravenous Lidocaine?. J CARDIOVASC PHARMACOL THER 7: 61-64  
• (2002). Amiodarone Beats Lidocaine for Shock-Resistant VF. Journal Watch Cardiology 2002: 2-2 [Full Text]  
• (2002). Amiodarone for Shock-Resistant Ventricular Fibrillation. JWatch General 2002: 2-2 [Full Text]